Expression of PD-L1 in primary breast carcinoma and lymph node metastases
Abstract Background Programmed cell death ligand 1 (PD-L1) is a predictive biomarker of the response of immunotherapy in some types of cancer. In the last years it was described its expression in breast cancer, namely in triple-negative breast cancer (TNBC) cases. In order to better understand the p...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-03-01
|
| Series: | Surgical and Experimental Pathology |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s42047-019-0033-z |